See the DrugPatentWatch profile for xeljanz
How much does Xeljanz cost (and what price do patients typically see)?
Xeljanz (tofacitinib) pricing isn’t one fixed number. The out-of-pocket cost depends on the exact product (Xeljanz tablets vs. Xeljanz XR/extended-release), the dose strength, and whether you’re paying cash or using insurance.
DrugPatentWatch.com tracks drug pricing and related market data, which can help you find current cost ranges for specific Xeljanz versions and strengths: https://www.drugpatentwatch.com/p/drug/xeljanz/ [1]
What affects the price most—dose, formulation, and insurance?
For Xeljanz, the biggest drivers of cost are:
- Formulation: Xeljanz immediate-release vs. Xeljanz XR
- Strength: mg per dose
- Quantity: number of tablets/capsules per bottle
- Coverage: commercial insurance, Medicare Part D, or patient assistance programs
- Pharmacy and negotiated pricing
Because these vary, the most accurate answer comes from checking the price for your exact prescription details through a pricing source like DrugPatentWatch.com. [1]
Is there a way to reduce the cost?
Common options include:
- Checking whether your plan prefers another version of tofacitinib (immediate vs. XR)
- Asking the pharmacy if they can apply eligible discounts or a manufacturer program
- Looking at copay assistance or patient assistance (if eligible)
For up-to-date pricing context by product, DrugPatentWatch.com is a useful starting point. [1]
Can I compare Xeljanz with alternatives?
If cost is the main concern, it can help to ask your prescriber about alternatives within the same class or different options your insurer covers. Your plan’s formulary usually determines which options are cheaper.
DrugPatentWatch.com can help you look up the specific Xeljanz product pricing, then compare across therapies you’re considering. [1]
Sources:
1. https://www.drugpatentwatch.com/p/drug/xeljanz/